Multaq 400 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FZ0R0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,524
Award facts
- Contract value 100% obligated
- $17,524.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,524.04 to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60-count units) on January 8, 2026, with an ultimate completion date of January 9, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at up to $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems. The company has demonstrated extensive capability in fulfilling federal pharmaceutical supply requirements across multiple therapeutic domains, with its contract portfolio encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order for MULTAQ, an antiarrhythmic medication used in cardiac treatment, exemplifies the company's role in supplying essential prescription pharmaceuticals to support the Defense Health Agency and other government healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FZ0R0?
SPE2DR26FZ0R0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FZ0R0 worth?
The government has obligated $17,524 on SPE2DR26FZ0R0.
Is contract SPE2DR26FZ0R0 an order under another contract?
Yes. SPE2DR26FZ0R0 is a delivery order under SPE2DR25D2018, an indefinite delivery contract.
Was contract SPE2DR26FZ0R0 competed?
The extent of competition for SPE2DR26FZ0R0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award